dc.creator | Belo | |
dc.creator | V. A.; Luizon | |
dc.creator | M. R.; Lacchini | |
dc.creator | R.; Miranda | |
dc.creator | J. A.; Lanna | |
dc.creator | C. M. M.; Souza-Costa | |
dc.creator | D. C.; Tanus-Santos | |
dc.creator | J. E. | |
dc.date | 2015-JAN | |
dc.date | 2016-06-07T13:14:08Z | |
dc.date | 2016-06-07T13:14:08Z | |
dc.date.accessioned | 2018-03-29T01:34:57Z | |
dc.date.available | 2018-03-29T01:34:57Z | |
dc.identifier | | |
dc.identifier | The Effects Of Nampt Haplotypes And Metabolic Risk Factors On Circulating Visfatin/nampt Levels In Childhood Obesity. Nature Publishing Group, v. 39, p. 130-135 JAN-2015. | |
dc.identifier | 0307-0565 | |
dc.identifier | WOS:000347394000019 | |
dc.identifier | 10.1038/ijo.2013.173 | |
dc.identifier | http://www.nature.com/ijo/journal/v39/n1/full/ijo2013173a.html | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/241569 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1305267 | |
dc.description | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description | OBJECTIVE: Polymorphisms in the NAMPT gene, which encodes the adipocytokine visfatin/nicotinamide phosphorybosil transferase (NAMPT), affect the circulating visfatin/NAMPT levels and are associated with obesity and cardiovascular diseases. However, no study has tested the hypothesis that NAMPT haplotypes could affect visfatin/NAMPT levels in case of childhood obesity. We investigated the effects of traditional metabolic risk factors (MRFs) and NAMPT polymorphisms T/C (rs1319501) and A/G (rs3801266) or haplotypes on visfatin/NAMPT levels in obese children and adolescents, and whether NAMPT polymorphisms and/or haplotypes are associated with susceptibility to childhood obesity. METHODS: We studied 175 control, 99 obese and 82 obese with >= 3 MRFs children and adolescents. Genotypes were determined by a Taqman allele discrimination assay and real- time PCR. The plasma visfatin/NAMPT level was measured using an enzyme immunoassay. RESULTS: Obese children and adolescents with >= 3 MRFs had higher plasma visfatin/NAMPT levels in comparison with control children and adolescents (P < 0.05). Although positive associations were observed between visfatin/NAMPT and body mass index (rs = 0.157; P = 0.034) as well as visfatin/NAMPT and waist circumference (rs = 0.192; P = 0.011), visfatin/NAMPT and high- density lipoprotein cholesterol were inversely associated (rs = -0.162; P = 0.031). No significant differences in genotype, allele or haplotype frequency distributions for the studied polymorphisms were found when the three groups were compared. However, higher plasma visfatin/NAMPT levels were found in control and obese subjects carrying the GG genotype for the A/G (rs3801266) polymorphism (P < 0.05) but not in obese children with X3 MRFs. Moreover, control subjects carrying the 'T-G' haplotype showed higher plasma visfatin/NAMPT levels. NAMPT genotypes or haplotypes were not associated with childhood obesity. CONCLUSIONS: Obesity in children with >= 3 MRFs increases plasma visfatin/NAMPT levels, and this marker was associated with body mass index and waist circumference. The A/G polymorphism and NAMPT haplotypes affect plasma visfatin/NAMPT levels in controls but not in obese children with >= 3 MRFs. These results suggest that obesity and MRFs are more influential than genetic polymorphisms in the determination of visfatin/NAMPT levels in obese children. Further research is necessary to explain why the GG genotype is not associated with increased visfatin/NAMPT levels in obese children with >= 3 MRFs. | |
dc.description | 39 | |
dc.description | 1 | |
dc.description | | |
dc.description | 130 | |
dc.description | 135 | |
dc.description | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description | | |
dc.description | | |
dc.description | | |
dc.language | en | |
dc.publisher | NATURE PUBLISHING GROUP | |
dc.publisher | | |
dc.publisher | LONDON | |
dc.relation | INTERNATIONAL JOURNAL OF OBESITY | |
dc.rights | fechado | |
dc.source | WOS | |
dc.subject | Type-2 Diabetes-mellitus | |
dc.subject | Homeostasis Model Assessment | |
dc.subject | Insulin-resistance | |
dc.subject | Serum Visfatin | |
dc.subject | Glucose-metabolism | |
dc.subject | Genetic-variations | |
dc.subject | Adipose-tissue | |
dc.subject | Visceral Fat | |
dc.subject | Children | |
dc.subject | Adolescents | |
dc.title | The Effects Of Nampt Haplotypes And Metabolic Risk Factors On Circulating Visfatin/nampt Levels In Childhood Obesity | |
dc.type | Artículos de revistas | |